المؤلفون: Kahn SE; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle., Deanfield JE; Institute of Cardiovascular Science, University College London, London, U.K., Jeppesen OK; Novo Nordisk A/S, Søborg, Denmark., Emerson SS; Department of Biostatistics, University of Washington, Seattle, WA., Boesgaard TW; Novo Nordisk A/S, Søborg, Denmark., Colhoun HM; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, U.K., Kushner RF; Department of Medicine, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL., Lingvay I; Department of Internal Medicine/Endocrinology and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX., Burguera B; Endocrinology & Metabolism Institute, Cleveland Clinic, Cleveland, OH., Gajos G; Department of Coronary Artery Disease and Heart Failure, Jagiellonian University Medical College, Kraków, Poland., Horn DB; Department of Surgery, John P. and Katherine G. McGovern Medical School, University of Texas, Houston, TX., Hramiak IM; Western University, London, Ontario, Canada., Jastreboff AM; Endocrinology and Metabolism, Department of Medicine, and Pediatric Endocrinology, Department of Pediatrics, Yale School of Medicine, New Haven, CT., Kokkinos A; First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Maeng M; Department of Cardiology, Aarhus University Hospital, and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Matos ALSA; Novo Nordisk A/S, Søborg, Denmark., Tinahones FJ; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND), CIBERobn, and Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Malaga University, Málaga, Spain., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic, and Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH., Ryan DH; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle.; Pennington Biomedical Research Center, Baton Rouge, LA.

مؤلفون مشاركون: SELECT Trial Investigators

المصدر: Diabetes care [Diabetes Care] 2024 Aug 01; Vol. 47 (8), pp. 1350-1359.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE

مواضيع طبية MeSH: Glucagon-Like Peptides*/therapeutic use , Overweight*/drug therapy , Overweight*/complications , Obesity*/drug therapy , Obesity*/complications , Blood Glucose*/drug effects , Blood Glucose*/metabolism , Glycated Hemoglobin*/metabolism, Humans ; Male ; Middle Aged ; Female ; Aged ; Double-Blind Method ; Hypoglycemic Agents/therapeutic use

المؤلفون: Mathieu C; Clinical and Experimental Endocrinology, Katholieke Universiteit Leuven, Leuven, Leuven, Belgium. Electronic address: chantal.mathieu@uzleuven.be., Ásbjörnsdóttir B; Novo Nordisk A/S, Søborg, Denmark., Bajaj HS; LMC Diabetes and Endocrinology, Brampton, ON, Canada., Lane W; Mountain Diabetes and Endocrine Center, Asheville, NC, USA., Matos ALSA; Novo Nordisk A/S, Søborg, Denmark., Murthy S; Lifecare Hospital and Research Centre, Bangalore, India., Stachlewska K; Novo Nordisk A/S, Søborg, Denmark., Rosenstock J; Velocity Clinical Research at Medical City, Dallas, TX, USA.

المصدر: Lancet (London, England) [Lancet] 2023 Jun 10; Vol. 401 (10392), pp. 1929-1940. Date of Electronic Publication: 2023 May 05.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Insulin Glargine*/therapeutic use , Insulin, Long-Acting*/therapeutic use, Adult ; Humans ; Blood Glucose/analysis ; Blood Glucose Self-Monitoring ; Hypoglycemic Agents/therapeutic use ; Treatment Outcome ; Drug Substitution

المؤلفون: Nordgaard C; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Doll S; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.; Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark., Matos ALSA; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Høeberg M; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Kazi JU; Division of Translational Cancer Research and Lund Stem Cell Center, Lund University, Sweden., Friis S; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Stenvang J; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Rönnstrand L; Division of Translational Cancer Research and Lund Stem Cell Center, Lund University, Sweden.; Division of Oncology, Skåne University Hospital, Lund, Sweden., Mann M; Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.; Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark., Manuel Afonso Moreira J; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

المصدر: Molecular oncology [Mol Oncol] 2019 Dec; Vol. 13 (12), pp. 2646-2662. Date of Electronic Publication: 2019 Oct 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Signal Transduction*, Colorectal Neoplasms/*metabolism , Proto-Oncogene Proteins c-kit/*metabolism , Tissue Inhibitor of Metalloproteinase-1/*metabolism, Cell Line, Tumor ; Colorectal Neoplasms/genetics ; Humans ; Proto-Oncogene Mas ; Proto-Oncogene Proteins c-kit/genetics ; Proto-Oncogene Proteins p21(ras)/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism ; Tissue Inhibitor of Metalloproteinase-1/genetics

المؤلفون: Aaberg-Jessen C; Department of Pathology, Odense University Hospital, J.B. Winsloews Vej 15, 5000, Odense, Denmark.; Department of Nuclear Medicine, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense, Denmark., Sørensen MD; Department of Pathology, Odense University Hospital, J.B. Winsloews Vej 15, 5000, Odense, Denmark. mia.soerensen@rsyd.dk.; Department of Clinical Research, University of Southern Denmark, J.B. Winsloews Vej 19, 5000, Odense, Denmark. mia.soerensen@rsyd.dk., Matos ALSA; Cancer Research Group, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Strandboulevarden 49, 2100, Copenhagen, Denmark., Moreira JM; Cancer Research Group, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Strandboulevarden 49, 2100, Copenhagen, Denmark., Brünner N; Cancer Research Group, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Strandboulevarden 49, 2100, Copenhagen, Denmark., Knudsen A; Department of Pathology, Odense University Hospital, J.B. Winsloews Vej 15, 5000, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, J.B. Winsloews Vej 19, 5000, Odense, Denmark., Kristensen BW; Department of Pathology, Odense University Hospital, J.B. Winsloews Vej 15, 5000, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, J.B. Winsloews Vej 19, 5000, Odense, Denmark.

المصدر: BMC cancer [BMC Cancer] 2018 Mar 09; Vol. 18 (1), pp. 270. Date of Electronic Publication: 2018 Mar 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*metabolism , Cell Membrane/*metabolism , Glioblastoma/*metabolism , Glioblastoma/*pathology , Neoplastic Stem Cells/*pathology , Tetraspanin 30/*metabolism , Tissue Inhibitor of Metalloproteinase-1/*metabolism, Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Cohort Studies ; Female ; Follow-Up Studies ; Humans ; Immunoprecipitation ; Male ; Middle Aged ; Neoplastic Stem Cells/metabolism ; Prognosis ; Survival Rate ; Young Adult